
Let's take a closer look at the current UNH stock quote and investor trends.
UNH stock has been on a steady rise, with a 12-month high of $434.89 and a 52-week low of $263.85.
The company's strong financial performance has attracted the attention of many investors, with a market capitalization of over $550 billion.
Investors are closely watching the company's revenue growth, which has consistently been above 10% in the past few years.
UNH's diversified business model, including its pharmacy benefits management and healthcare services segments, has contributed to its steady growth.
Financial Analysis
Let's take a closer look at the financial analysis of UNH stock quote. UNH stock has consistently delivered strong earnings growth, with an average annual increase of 13.5% over the past five years. This is a testament to the company's ability to drive revenue and profitability.
The company's strong financial performance has been driven by its diversified revenue streams, including its hospital and medical services segment, which generates a significant portion of its revenue. UNH stock has a price-to-earnings ratio of 16.3, which is lower than the industry average.
UNH's operating margin has also been impressive, averaging 5.5% over the past five years. This is a result of the company's focus on cost control and operational efficiency. The company's strong balance sheet, with a debt-to-equity ratio of 0.4, provides a solid foundation for future growth.
You might enjoy: Dow Jones Industrial Average Dividend Yield
Valuation and Growth
Valuation and Growth are key factors to consider when evaluating UNH stock. The company's valuation ratios indicate that its stocks may be considered cheaper compared to others.
The Trailing PE of 34.13 suggests that UNH's stock price is relatively high compared to its earnings. In contrast, the Forward PE of 17.79 indicates a lower valuation based on future earnings estimates.
UNH's Price/FCF ratio of 38 is higher than some of its peers, indicating that investors are willing to pay a premium for the company's future cash flows.
Here's a breakdown of UNH's valuation ratios:
In terms of growth, UNH's 3-Year Revenue Growth Rate of 12.7% is impressive, indicating a strong track record of revenue expansion. The 3-Year EBITDA Growth Rate of 2.2% suggests a more modest growth in earnings before interest, taxes, depreciation, and amortization.
UNH's growth prospects are also supported by its Future 3-5Y EPS without NRI Growth Rate Estimate of 11.22%, indicating a promising outlook for earnings per share.
Here's a summary of UNH's growth metrics:
Investor Insights
Analysts are overwhelmingly bullish on UNH stock, with an average rating of "Strong Buy" from 21 analysts.
The 12-month stock price forecast is a significant increase of 14.74% from the latest price, reaching $623.6.
UNH has been sold off due to market overreaction to a top-line miss and mixed guidance, but robust growth in Optum Rx and Optum Health provides a contrarian buy opportunity.
Here are some key statistics on UNH's dividend and buyback policies:
Company Performance
UnitedHealth Group's financial performance in 2024 was impressive, with revenue reaching $400.28 billion.
This represents a 7.71% increase from the previous year's revenue of $371.62 billion.
Despite the impressive revenue growth, the company's earnings took a hit, decreasing by 35.64% to $14.41 billion.
Price and Trading
The price of UNH stock can be volatile, with a 52-week range of $215.92 to $337.51 per share.
UNH stock is considered a growth stock, with a price-to-earnings (P/E) ratio of around 22.5, indicating that investors are willing to pay a premium for its future earnings potential.
In terms of trading, UNH stock is highly liquid, with an average daily trading volume of over 2 million shares.
Liquidity
Liquidity is a crucial aspect of a company's financial health. A high liquidity ratio indicates that a company can easily meet its short-term financial obligations.
The cash ratio is a key metric in determining liquidity. UNH's cash ratio is 0.28, which is relatively low.
The current ratio is another important liquidity metric. A higher current ratio is generally better, but UNH's current ratio is only 0.83.
Here are the liquidity ratios for UNH, including the cash ratio, current ratio, and quick ratio:
A company's days sales outstanding (DSO) and days payable outstanding (DPO) can also provide insight into its liquidity. UNH's DSO is 20.79 days, indicating that it takes a relatively long time to collect payments from customers. On the other hand, its DPO is 46.75 days, indicating that it takes a relatively long time to pay its suppliers.
Readers also liked: How Long to Get Funds after Selling Stock
Watch Price Levels After Disappointing Results
UnitedHealth Group's shares fell sharply after reporting fourth-quarter results below Wall Street's expectations.

The disappointing results led to a lackluster outlook from the company, which is a major red flag for investors.
The health insurer issued a warning about higher medical costs, which is a significant concern for its business model.
This news caused a significant drop in UnitedHealth's stock price, making it an important time to watch its price levels closely.
Investors who were holding onto UnitedHealth shares at the time were likely left with significant losses.
The company's stock price slump serves as a reminder that even established companies can experience significant price drops in response to disappointing results.
Frequently Asked Questions
Is UNH a good buy right now?
UnitedHealth (UNH) is considered a strong buy by 20 Wall Street analysts, indicating a potential 26.69% increase from its current price. Analysts' consensus suggests UNH is a promising investment opportunity, but it's essential to do your own research before making a decision.
What is the future price of UNH?
According to 19 analysts, the predicted future price of UNH stock is around $617.63, representing a 22.10% increase from its current price. This estimate ranges from $460 to $675, indicating some variation in market expectations.
What is the symbol for UnitedHealthcare?
The symbol for UnitedHealth Group's common stock is UNH, listed on the New York Stock Exchange (NYSE). You can purchase UNH stock through a broker, not directly from the company.
What is the symbol for UnitedHealth Group?
The symbol for UnitedHealth Group is UNH, listed on the New York Stock Exchange (NYSE). You can buy UNH stock through a broker, not directly from the company.
Featured Images: pexels.com


